Rhythm management in pediatric heart failure.
There are several options now available for the management of arrhythmias and ventricular dysfunction in pediatric patients with heart failure. A hybrid approach that combines the expertise of heart failure and electrophysiology specialists may be well suited for the optimal management of these complex patients. Medical and device therapies may be synergistic in decreasing the morbidity and mortality in pediatric heart failure. Pediatric electrophysiology can now potentially offer therapies that can help prevent both arrhythmic and pump failure deaths, as well as improve functional capacity and quality of life. These therapies and the available supporting data relevant to pediatrics will be the focus of this review.
Berul
Charles I
CI
Children's Hospital, Harvard University, Boston, MA, USA.
Dubin
Anne M
AM
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000150:complications* / Q000628:therapy*; D002648:Child; D017147:Defibrillators, Implantable; D006333:Heart Failure / Q000150:complications* / Q000628:therapy*; D006801:Humans; D010372:Pediatrics / Q000379:methods; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000628:therapy
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents